Registered Owners
- View profile →
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 12345678910
owner
Direktorat Registrasi ObatValid
SITAGLIPTIN PHOSPHATE
by '-'
- BPOM Number
- GKL2457901817A1
- Approved
- 10 January 2025
- Expiry
- 7 November 2029
- Form
- TABLET SALUT SELAPUT
About This Registration
SITAGLIPTIN PHOSPHATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2457901817A1. Its current registration status is Valid, with the licence valid until 7 November 2029. The product is registered to ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA. BPOM first approved this registration in November 2024. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration data updated by BPOM
This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.
Registration Details
- Application
- newaero
- Packaging
- DUS, 3 BLISTER @10 TABLET SALUT SELAPUT
- Department
- Direktorat Registrasi Obat
- Data Last Updated
- 13 November 2025
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
Market Intelligence
- Owner Portfolio
- ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA holds 67 BPOM registrations
- Manufacturer Scale
- ETANA BIOTECHNOLOGIES INDONESIA - INDONESIA produces 67 registered products
- Registration Age
- Registered for 1 year, 8 months
FDA Cross-Reference
via openFDA- Generic Name
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- ORAL
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.